title: The role and clinical effectiveness of multimodality imaging in the management of cardiac complications of cancer and cancer therapy.
abstract: With the increasing number of individuals living with a current or prior diagnosis of cancer, it is important for the cardiovascular specialist to recognize the various complications of cancer and its therapy on the cardiovascular system. This is true not only for established cancer therapies, such as anthracyclines, that have well established cardiovascular toxicities, but also for the new targeted therapies that can have "off target" effects in the heart and vessels. The purpose of this informational statement is to provide cardiologists, cardiac imaging specialists, cardio-oncologists, and oncologists an understanding of how multimodality imaging may be used in the diagnosis and management of the cardiovascular complications of cancer therapy. In addition, this document is meant to provide useful general information concerning the cardiovascular complications of cancer and cancer therapy as well as established recommendations for the monitoring of specific cardiotoxic therapies.
authors.affiliation: Rhode Island Cardiovascular Institute, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, 593 Eddy Street, APC 737, Providence, RI, 02903, USA. raymond.russell@lifespan.org.
authors.forename: Raymond R
authors.initials: RR
authors.lastname: Russell
authors.affiliation: Cardiology Division, Western Connecticut Medical Center at Danbury Hospital, Danbury, CT, USA.
authors.forename: Jonathan
authors.initials: J
authors.lastname: Alexander
authors.affiliation: Section of Cardiovascular Medicine, New York Medical College and Westchester Medical Center, Valhalla, NY, USA.
authors.forename: Diwakar
authors.initials: D
authors.lastname: Jain
authors.affiliation: Division of Cardiology, Allegheny Health Network, Pittsburgh, PA, USA.
authors.forename: Indu G
authors.initials: IG
authors.lastname: Poornima
authors.affiliation: Division of Cardiovascular Medicine, Scripps Clinic, La Jolla, CA, USA.
authors.forename: Ajay V
authors.initials: AV
authors.lastname: Srivastava
authors.affiliation: Cardiology Division, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
authors.forename: Eugene
authors.initials: E
authors.lastname: Storozynsky
authors.affiliation: Cardiology Division, Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.|Nuclear Medicine Division, Department of Imaging Sciences, University of Rochester Medical Center, Rochester, NY, USA.
authors.forename: Ronald G
authors.initials: RG
authors.lastname: Schwartz
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D057791:Cardiac Imaging Techniques / Q000379:methods*; D019317:Evidence-Based Medicine; D006331:Heart Diseases / Q000000981:diagnostic imaging* / Q000209:etiology*; D006801:Humans; D064847:Multimodal Imaging / Q000379:methods*; D011832:Radiation Injuries / Q000000981:diagnostic imaging* / Q000209:etiology; D011878:Radiotherapy / Q000009:adverse effects*; D014055:Tomography, Emission-Computed / Q000379:methods
chemical_list: D000970:Antineoplastic Agents
keywords: Multimodality imaging; cancer therapy; cardiac complications; cardio-oncology